Streetbeat News

Partnerships

DCGO

DocGo, a leading provider of last-mile mobile health services and integrated medical mobility solutions, has been awarded the Health Care Staffing Services Certification from The Joint Commission. This certification recognizes DocGo's commitment to providing and continuously improving health care staffing services.

Portfolio Pulse from Bill Haddad

October 18, 2023 | 11:36 am

ARM

META

Meta Platforms Inc is looking to leverage artificial intelligence (AI) chatbots as a tool for advertisers. The company's Chief Product Officer, Chris Cox, cited a significant business demand for better tools. OpenAI is working to make its ChatGPT cheaper and faster for better accessibility. ARM Holdings Plc is also leveraging AI in areas where they struggle to hire enough talent. Meta is exploring ways to monetize AI after releasing free AI chatbots to users on Instagram and WhatsApp.

Portfolio Pulse from Anusuya Lahiri

October 18, 2023 | 11:19 am

TELL

VGAS

Tellurian Inc. (TELL) and Verde Clean Fuels, Inc. (VGAS) are identified as the most oversold stocks in the energy sector, presenting a potential buying opportunity. Tellurian recently secured a deal with Baker Hughes for the Driftwood LNG project, while Verde Clean Fuels reported a Q2 loss but is progressing towards the first commercial deployment of its STG+ process.

Portfolio Pulse from Lisa Levin

October 18, 2023 | 11:08 am

GILD

HOOK

Hookipa Pharma has announced that the Journal of Infectious Diseases has published preclinical data on HB-400, a therapeutic vaccine for chronic Hepatitis B. The vaccine was developed in collaboration with Gilead Sciences.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 11:05 am

ANTX

AN2 Therapeutics has signed a license agreement with the University of Georgia Research Foundation to develop a boron-based therapy for Chagas disease. The preclinical activities have been funded by non-dilutive grant funding from Wellcome.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 11:03 am

GOOGL

INFY

Infosys (INFY) is expanding its alliance with Google Cloud (GOOGL) to help enterprises build AI-powered experiences. Infosys will create the new global Generative AI Labs to develop industry-specific AI solutions and platforms. Infosys will also train 20,000 practitioners on Google Cloud’s gen AI solutions, including Vertex AI and Duet AI in Google Workspace.

Portfolio Pulse from Charles Gross

October 18, 2023 | 10:03 am

WBA

Walgreens and the Cardiovascular Research Foundation (CRF) have announced a collaboration to advance the PREVUE-VALVE study. This clinical trial aims to quantify the prevalence of valvular heart disease (VHD) among older Americans and facilitate the development of new therapies and tools for VHD detection and diagnosis.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 10:01 am

MSFT

OpenAI's CEO Sam Altman has denied having a strained relationship with Microsoft's CEO Satya Nadella, despite reported clashes over the integration of OpenAI's model with Microsoft's Bing chatbot and concerns over Microsoft's $10 billion investment in OpenAI. Altman sees the rise of chatbots as friendly competition and stated that both companies want as much usage of their models as possible. Microsoft is reportedly looking to decrease its dependence on OpenAI by developing its own AI model.

Portfolio Pulse from Navdeep Yadav

October 18, 2023 | 8:47 am

AAPL

MSFT

SFTBF

OpenAI CEO Sam Altman has denied rumors of working on the 'iPhone of AI', a relief to Apple Inc. Altman confirmed that he, along with former Apple designer Sir Jony Ive and SoftBank's Masayoshi Son, is working on a consumer-centric device, but it will not compete with smartphones. Microsoft, one of the largest shareholders of OpenAI, will also contribute to the project.

Portfolio Pulse from Rounak Jain

October 18, 2023 | 8:00 am

GSK

PFE

ViiV Healthcare, a joint venture of GlaxoSmithKline (GSK) and Pfizer (PFE), is set to present 23 abstracts from its HIV treatment and prevention portfolio at the EACS 2023. The presentation will include long-term and real-world data from ViiV Healthcare's portfolio of medicines, including long-acting and 2-drug regimens.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 7:32 am